Substance / Medication

Rosiglitazone maleate

Overview

Clinical overview including description, indications, and evidence base is pending physician authorship or FDA SPL integration. Graph-derived relationship data is available below.

Indications & Related Conditions

Conditions associated via SNOMED clinical relationships

Administration & Protocol

Dosing, route, and treatment protocol

Administration details including route, dosing schedules, preparation instructions, and contraindications are pending physician authorship.

Monitoring & Follow-Up

Biomarkers relevant to this intervention via related conditions

Clinical Trials

903 trials linked to this intervention

903
Total Trials
103
Recruiting
282
With Results

Research Evidence

Published studies and systematic reviews

Sort:
Preparation of rosiglitazone maleate sustained-release floating microspheres for improved bioavailability.
Hu Lian-Dong, Xing Qian-Bin, Shang Chuang et al. · Pharmazie · 2010
PMID: 20662314RCT
Development and in vitro evaluation of floating rosiglitazone maleate microspheres.
Rao M R P, Borate S G, Thanki K C et al. · Drug Dev Ind Pharm · 2009
PMID: 19337874Observational
Development and validation of a selective online dissolution method for rosiglitazone maleate.
Shaikh Saleem, Muneera M S, Thusleem O A et al. · J Chromatogr Sci · 2007
PMID: 17626717Observational
[The safety and efficacy of rosiglitazone maleate in the treatment of patients with type 2 diabetes mellitus in China].
Zhu Xi-Xing, [object Object] · Zhonghua Nei Ke Za Zhi · 2003
PMID: 14514393Observational
A Sensitive HPTLC Method for the Estimation of Glibenclamide, Rosiglitazone Maleate and Metformin Hydrochloride from a Multicomponent Dosage Form.
Bhende Swati D, Varanasi Murali Balaram, Abbulu Konde · J Chromatogr Sci · 2020
PMID: 32086517Other
A Cost Effective (QbD) Approach in the Development and Optimization of Rosiglitazone Maleate Mucoadhesive Extended Release Tablets -and.
Chappidi Suryaprakash Reddy, Bhargav Eranti, Marikunte Venkataranganna et al. · Adv Pharm Bull · 2019
PMID: 31380254OtherFull text (PMC)

Research data from MEDLINE/PubMed

Benefits & Expected Outcomes

Benefits, expected outcomes, efficacy data, and NNT (Number Needed to Treat) are pending physician authorship and evidence review.

Risks & Side Effects

Risk profile, common and serious adverse effects, contraindications, and drug interactions are pending physician authorship.

Related Symptoms

Symptoms associated with conditions this intervention addresses

No related symptoms have been mapped yet. Symptom linkages are derived through associated conditions.

Alternatives & Comparisons

Alternative treatments, comparison data, and clinical decision support are pending physician authorship.

Medical Disclaimer

This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider regarding any medical condition or treatment plan.

Do not start, stop, or change any treatment without consulting your healthcare provider.

Health Goals

Goals connected through associated conditions

Quick Facts

Type
Substance / Medication
Fully Specified Name
Rosiglitazone maleate (substance)
SNOMED CT
116096001
UMLS CUI
C0795660

Clinical Data

This intervention maps to 10 entities in the Healos knowledge graph.

1
Conditions
4
Biomarkers
3
Specialists
0
Symptoms
903
Clinical Trials

Data is sourced from SNOMED CT, UMLS, and the Healos clinical knowledge graph. Content sections marked as pending require physician authorship. Consult a healthcare provider before starting any treatment.